Trial Radar IA
Lo studio clinico NCT07351110 (PINPOINT) per Diabete, Cervical Cancer (Early Detection), Obesity & Overweight è non ancora in arruolamento. Consulti la vista a schede del Radar degli Studi Clinici e gli strumenti di scoperta IA per tutti i dettagli. Oppure, ponga pure una domanda qui.
Un studio corrisponde ai criteri del filtro
Vista a schede
Torna alla ricerca

Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions. (PINPOINT) 20 Prevenzione

Non ancora in arruolamento
I dettagli dello studio clinico sono disponibili principalmente in inglese. Tuttavia, Trial Radar IA può essere d'aiuto! Basta cliccare su 'Spiega lo studio' per visualizzare e discutere le informazioni sullo studio nella lingua selezionata.
La sperimentazione clinica NCT07351110 (PINPOINT) è uno studio interventistico per Diabete, Cervical Cancer (Early Detection), Obesity & Overweight, attualmente non ancora in arruolamento. L'arruolamento dovrebbe iniziare il 15 marzo 2026, con l'obiettivo di raggiungere 20 partecipanti. Sotto la guida di l'Università della Florida, dovrebbe concludersi entro il 24 dicembre 2026. I dati più recenti da ClinicalTrials.gov sono stati aggiornati l'ultima volta il 20 gennaio 2026.
Sommario breve
Our overarching goal is to adapt and test the PINPOINT intervention -PatIent Navigation for the Prevention of CervIcal CaNcer inTervention. We will test the PINPOINT intervention among patients with high-risk profiles for cervical cancer who do not meet the recommended screening for cervical cancer.
Descrizione dettagliata
We will test the PINPOINT intervention among patients with high-risk profiles for cervical cancer who do not meet the recommended screening for cervical cancer. We will use the six steps of the Intervention Mapping approach to guide the process of testing the intervention. This project aligns with the current efforts at the University of Florida Health Cancer Institute (UFHCI) and UF Health Internal Medicine to impro...Mostra di più
Titolo ufficiale

Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions. Aim 3: Assess the Feasibility and Acceptability of the PINPOINT Intervention.

Patologie
DiabeteCervical Cancer (Early Detection)Obesity & Overweight
Pubblicazioni
Articoli scientifici e documenti di ricerca pubblicati su questo studio clinico:
Altri ID dello studio
Numero NCT
NCT07351110
Data di inizio (effettiva)
2026-03-15
Ultimo aggiornamento pubblicato
2026-01-20
Data di completamento (stimata)
2026-12-24
Arruolamento (previsto)
20
Tipo di studio
Interventistico
FASE
N.D.
Stato
Non ancora in arruolamento
Parole chiave
cervical cancer screening
self-collection
self-sampling
Scopo principale
Selezione
Allocazione
Randomizzato
Modello di intervento
In parallelo
Mascheramento
Nessuno (studio in aperto)
Bracci / Interventi
Gruppo/Braccio di partecipantiIntervento/Trattamento
SperimentaleIntervention
PINPOINT intervention arm will entail assigning patients to a patient navigator to assist them with screening reminders and address any barriers they have to screening, education on cervical cancer screening, and patients will also be offered the opportunity to self-collect their sample for cervical cancer screening.
patient navigation and self-collection
Patients will receive a combination of patient navigation, education, and cervical cancer self-collection sampling as part of the intervention to support cervical cancer screening.
Nessun interventoControl Arm
No intervention arm, patients will receive reminders for screening according to current clinical practice
N.D.
Esito primario
Misure di esitoDescrizione della misuraArco temporale
Cervical cancer screening
receiving cervical cancer screening either via self-collection, pap smear, or hpv testing
within 6 months
Esito secondario
Misure di esitoDescrizione della misuraArco temporale
Acceptability
How agreeable or satisfactory participants find the intervention or implementation strategy. Questions include, HPV Self-Collection meets my approval, HPV Self-Collection is appealing to me, I like HPV Self-Collection, and I welcome HPV Self-Collection. Participants will fill a 4 point likert scale for each, (completely disagree, disagree, neither agree not disagree, agree, completely agree).
from enrollment until they complete screening or at the end of the trial at 6 months
Appropriateness
The perceived fit or compatibility of the intervention for a specific setting, provider, or consumer, or to address a problem. Questions include, HPV Self-Collection seems fitting, HPV Self-Collection seems suitable, HPV Self-Collection seems applicable., and HPV Self-Collection seems like a good match. Participants will fill a 4 point likert scale for each, (completely disagree, disagree, neither agree not disagree, agree, completely agree).
from enrollment until they complete screening or at the end of the trial at 6 months
Feasibility measure
\- The extent to which an intervention can be successfully used in a given setting. Questions include, HPV Self-Collection seems implementable, HPV Self-Collection seems possible, HPV Self-Collection seems doable, and HPV Self-Collection seems easy to use. Participants will fill a 4 point likert scale for each, (completely disagree, disagree, neither agree not disagree, agree, completely agree).
from enrollment until they complete screening or at the end of the trial at 6 months
Assistente alla partecipazione
Criteri di eleggibilità

Età idonea
Adulto, Adulto anziano
Età minima
25 Years
Sessi idonei
Femmina
Accetta volontari sani
Sì

The following eligibility criteria will be used to determine inclusion into the study:

  1. Using the American Cancer Society (ACS) screening recommendations, adults aged over the age of 25 will be eligible
  2. Active UF Internal Medicine patient and has had an appointment in the last 2 months.
  3. Assigned sex at birth is female
  4. Have Obesity or Type 2 Diabetes
  5. Not currently pregnant (self-report)
  6. Have not given birth in the prior 12 weeks
  7. No previous history of cervical cancer
  8. No previous history of a hysterectomy
  9. Have not undergone cancer screening in the past 3 years or more
  10. Reside in the UFHCI Catchment Area (Alachua, Baker, Bradford, Citrus, Clay, Columbia, Dixie, Gadsden, Gilchrist, Hamilton, Jefferson, Lafayette, Lake, Leon, Levy, Madison, Marion, Putnam, Sumter, Suwannee, Taylor, UnioF1n, or Wakulla County).
  11. Have a mobile phone or access to a mobile phone that can be used to receive messages, or a valid email address.
  12. Are not currently scheduled to receive cervical cancer screening via clinician sampling (pap smear).

  • Previous history of cervical cancer
  • Total hysterectomy
  • Pregnant
University of Florida logoUniversità della Florida296 studi clinici attivi da esplorare
National Cancer Institute (NCI) logoIstituto nazionale dei tumori, Estados Unidos
Contatti principali dello studio
Contatto: Rahma Mkuu, PhD, (352) 294-8419, [email protected]
Contatto: Daniela Rivero-Mendoza, MS., [email protected]
2 Centri dello studio in 1 paesi

Florida

UF Health Internal Medicine, Gainesville, Florida, 32611, United States
University of Florida, Gainesville, Florida, 32611, United States